The effect of a corticosteroid cream and a barrier-strengthening moisturizer in hand eczema. A double-blind, randomized, prospective, parallel group clinical trial

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 5, 2012, Pages 597-601

  Loden M ^a,b   Wiren K ^a   Smerud, K T ^c   Meland, N ^c   Honnas H ^c   Mork G ^d   Lutzow Holm C ^e   Funk, J ^f   Meding, B ^g  

^a ACO HUD NORDIC AB   (Sweden)

^b Eviderm Institute   (Sweden)

^c Smerud Medical Research International AS   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Dr Funk's Hudklinikk AS ^*  (Norway)

^f Dr Funk's Hudklinikk AS   (Norway)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HAND ECZEMA; HUMAN; MALE; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCORING SYSTEM; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

EID: 84860223273     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04128.x     Document Type: Article

References (27)

1. Meding B, Wrangsjo K, Jarvholm B,. Fifteen-year follow-up of hand eczema: persistence and consequences. Br J Dermatol 2005; 152: 975-980. (Pubitemid 40704938)
2. English J, Aldridge R, Gawkrodger DJ, et al. Consensus statement on the management of chronic hand eczema. Clin Exp Dermatol 2009; 34: 761-769.
3. Green C, Colquitt JL, Kirby J, Davidson P,. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol 2005; 152: 130-141.
4. Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G,. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 1999; 140: 882-886. (Pubitemid 29238460)
5. Holden C, English J, Hoare C, et al. Advised best practice for the use of emollients in eczema and other dry skin conditions. J Dermatolog Treat 2002; 13: 103-106.
6. Hoare C, Li Wan Po A, Williams H,. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1-191.
7. Buraczewska I, Berne B, Lindberg M, Torma H, Loden M,. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 2007; 156: 492-498.
8. Held E, Sveinsdottir S, Agner T,. Effect of long-term use of moisturizers on skin hydration, barrier function and susceptibility to irritants,. Acta DermVenereol (Stockh) 1999; 79: 49-51. (Pubitemid 29079329)
9. Zachariae C, Held E, Johansen JD, Menne T, Agner T,. Effect of a moisturizer on skin susceptibility to NiCl2. Acta Derm Venereol 2003; 83: 93-97. (Pubitemid 36433950)
10. Vilaplana J, Coll J, Trullás C, Axõn A, Pelejero C,. Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects. Acta Derm Venereol (Stockh) 1992; 72: 28-33.
11. Loden M, Wiren K, Smerud K, et al. Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema. An open, randomized, prospective, parallel group study. Acta Derm Venereol 2010; 90: 602-606.
12. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. (Pubitemid 24194579)
13. Meding B, Swanbeck G,. Epidemiology of different types of hand eczema in an industrial city. Acta Derm Venereol 1989; 69: 227-233. (Pubitemid 19110474)
14. Wester RC, Noonan PK, Maibach HI,. Frequency of application on percutaneous absorption of hydrocortisone. Arch Dermatol 1977; 113: 620-622. (Pubitemid 8098820)
15. Lucky AW, Leach AD, Laskarzewski P, Wenck H,. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997; 14: 321-324. (Pubitemid 27332923)
16. Watsky KL, Frieije L, Lenevue M-C, Wenck HA, Leffell DJ,. Water-in-oil emulsions as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis 1992; 50: 383-386.
17. ®). Br J Dermatol 1999; 140: 264-267. (Pubitemid 29111354)
18. Andersson A-C, Lindberg M, Lodén M,. The effect of two urea-containing creams on dry, eczematous skin in atopic patients. I. Expert, patient and instrumental evaluation. J Dermatolog Treat 1999; 10: 165-169. (Pubitemid 29438075)
19. Lodén M,. Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 1997; 36: 256-260. (Pubitemid 27246448)
20. Aalto-Korte K, Turpeinen M,. Transepidermal water loss and absorption of hydrocortisone in widespread dermatitis. Br J Dermatol 1993; 128: 633-635. (Pubitemid 23172021)
21. Demerjian M, Choi EH, Man MQ, Chang S, Elias PM, Feingold KR,. Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis. Exp Dermatol 2009; 18: 643-649.
22. Jensen JM, Pfeiffer S, Witt M, et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 2009; 124: R19-R28.
23. Kao JS, Fluhr JW, Man MQ, et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003; 120: 456-464. (Pubitemid 36298433)
24. Kolbe L, Kligman AM, Schreiner V, Stoudemayer T,. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 2001; 7: 73-77. (Pubitemid 32409572)
25. Buraczewska I, Berne B, Lindberg M, Loden M, Torma H,. Moisturizers change the mRNA expression of enzymes synthesizing skin barrier lipids. Arch Dermatol Res 2009; 301: 587-594.
26. Elias PM, Hatano Y, Williams ML,. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008; 121: 1337-1343.
27. Wiren K, Nohlgard C, Nyberg F, et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol 2009; 23: 1267-1272.